Both in Pharmaceuticals
Trevi Therapeutics vs SELLAS Life Sciences Group
Over the past year TRVI returned +28.8% and SLS returned +450.6%; their daily moves had a correlation of 0.26.
TRVI +28.8% SLS +450.6%Growth of $1, one year, split-adjusted
| Metric | TRVI | SLS |
|---|---|---|
| Price | $13.99 | $9.14 |
| Market cap | $1.99B | $1.85B |
| Today | +0.90% | +3.04% |
| 1 month | +6.1% | −19.4% |
| 6 months | −1.9% | +77.5% |
| Year to date | +11.7% | +142.4% |
| 1 year | +30.7% | +410.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $318.9M | $138.3M |
| Dividend yield | — | — |
| Volatility (60d) | 39.4% | 97.0% |
| Short % of float | 14.4% | 27.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).